Previous 10 | Next 10 |
Evolus, Inc. (EOLS) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Ashwin Agarwal – Vice President, Finance, Investor Relations and Treasury David Moatazedi – President and Chief Executive Officer Lauren Silvernail – Chief Finan...
Evolus (NASDAQ: EOLS ): Q1 GAAP EPS of -$0.59 beats by $0.15 . More news on: Evolus, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NEWPORT BEACH, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today reported financial results for the first quarter ended March 31, 2020 and provided a business...
NEWPORT BEACH, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its first quarter 2020 financial results and provide a business...
The FDA approves Galderma's Restylane Kysse, a hyaluronic acid filler, for lip augmentation and correction of upper perioral rhytids (wrinkles around the upper lip) in adults at least 21 years old. More news on: Allergan plc, Evolus, Inc., Revance Therapeutics, Inc., Healthcare stocks ne...
Evolus Inc. (NASDAQ: EOLS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Evolus announced a business update after the close as the aesthetics-focused company adjusts its cost structure and commercialization strategy in the fac...
NEWPORT BEACH, Calif., April 16, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced a pre-emptive plan to support the U.S. aesthetic neurotoxin market in ligh...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Image source: The Motley Fool. Evolus, Inc. (NASDAQ: EOLS) Q4 2019 Earnings Call Feb 25, 2020 , 8:00 a.m. ET Operator Continue reading
Evolus, Inc. (EOLS) Q4 2019 Results Conference Call February 25, 2020 08:00 AM ET Company Participants Ashwin Agarwal - VP, Finance, IR and Treasury David Moatazedi - President and CEO Lauren Silvernail - CFO and EVP Corporate Development Mike Jafar - Chief Marketing Officer ...
News, Short Squeeze, Breakout and More Instantly...
Total Net Revenue of $66.9 Million for Q2 2024, Up 36% from Q2 2023 Raises Full-Year 2024 Net Revenue Guidance to $260 Million to $270 Million, Representing Year-Over-Year Growth of 34% at the Top End Improved Quarterly GAAP Operating Loss to $7.7 Million; Delivered First Ever Qua...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will host an Investor Day on Thursday, September 12, 2024 in New York City. Attendees can join in-person or participate via webcast. The even...
Launching into this growth market 1 as part of the company’s geographic expansion strategy Evolus Australia established to drive medical education, training, marketing and sales to medical aesthetics healthcare professionals Evolus, Inc. (NASDAQ: EOLS), a perf...